BioCentury
ARTICLE | Financial News

Enterprise Therapeutics completes venture financing

February 16, 2015 8:00 AM UTC

Enterprise Therapeutics Ltd., Falmer, U.K. Business: Pulmonary, Inflammation Date completed: 2015-02-12 Type: Venture financing Raised: £1.6 million ($2.4 million) Investor: Epidarex Capital ...